Have you read these stories?

India's COVID-19 tally crosses 61-lakh mark

A spike of 70,589 new cases and 776 deaths were reported in the last 24 hours.
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 29 September, 2020, 09:57 AM IST | E-Paper


    Serum Institute initiates phase 2, 3 clinical study for potential COVID-19 vaccine

    According to the Clinical Trial Registry India, the scientific title of the study says that phase 2/3 clinical trial will be observer-blind, randomised, controlled study to determine the safety and immunogenicity of Covishield (COVID-19 vaccine) in healthy Indian adults.

    Here's how to check your AIIMS MBBS entrance test result

    The entrance test for the AIIMS MBBS course was held on May 28 at various centres ac...

    Steps taken by Modi govt in 6 years ensured India's success in containing pandemic effect: Naqvi

    India has not only become self-reliant in ma...

    Load More...
    The Economic Times